Standard BioTools Inc. (LAB) vs Mobia Medical, Inc. Common Stock (MOBI)

A side-by-side comparison of Standard BioTools Inc. and Mobia Medical, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LAB

Standard BioTools Inc.

$287M

$0.73HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT

MOBI

Mobia Medical, Inc. Common Stock

$302M

$9.08HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT

Total return — LAB vs MOBI

growth of $100 · dividends reinvested · last 1y

LAB -18.4% (-18.4%/yr)MOBI -36.1% (-36.1%/yr)LAB compounded faster over this window

LAB MOBI

LAB vs MOBI: by the numbers

•MOBI is the larger company ($302M vs $287M market cap).
•Both run net losses; LAB's is the smaller (-103.29% vs -145.12% net margin).

Metrics side by side

Valuation

Metric	LAB	MOBI
P/S ratio	3.39	N/A
P/B ratio	0.53	1.75

Profitability

Metric	LAB	MOBI
Gross margin	49.14%	81.07%
Operating margin	-109.34%	-144.71%
Net margin	-103.29%	-145.12%
ROE	-16.18%	N/A
ROIC	-14.06%	-122.21%

Growth (annualized)

Metric	LAB	MOBI
Revenue CAGR (5Y)	-10.62%	N/A
Total return CAGR (5Y)	-32.98%	N/A

Go deeper

Full LAB analysis Full MOBI analysis Interactive comparison tool

Dig into the metrics

Standard BioTools ROE Mobia Medical, Inc. Common Stock ROE Standard BioTools operating margin Mobia Medical, Inc. Common Stock operating margin Standard BioTools revenue growth Mobia Medical, Inc. Common Stock revenue growth Standard BioTools free cash flow Mobia Medical, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.